Summary: Stacie Dusetzina, PhD, department of health policy, Vanderbilt University School of Medicine, discusses the "desensitization" of society to cancer prescription drug costs, the role of advancing science in research and development and drug approvals for rare diseases, the H.R.3 bill in front of Congress, and solutions proposed by politicians for inflated Medicare Part D spending, among other topics. To read more about our host Chadi Nabhan and access exclusive materials and information about guests, visit journalofclinicalpathways.com/podcasts/outspoken-oncology. Journal of Clinical Pathways is the exclusive producer of the Outspoken Oncology podcast.
